Cathejell Lignocaine Gel 2% w/w

Cathejell Lignocaine Gel 2% w/w Dosage/Direction for Use

lidocaine

Manufacturer:

Pharmazeutische Fabrik Montavit

Distributor:

Pharmaforte
Full Prescribing Info
Dosage/Direction for Use
It is applied exclusively by a doctor or a healthcare professional.
The dose is adjusted individually.
The following dosage information serves as a guideline, the doctor's experience and the knowledge of the patient's physical state are important for the calculation of the suitable dosage.
The extent of absorption is especially high in the bronchial tree.
Application in the urethra before introducing a catheter, endoscope or other medical instruments: The collapsible syringes (hereinafter referred to as "syringes") contain 12.5 g gel each, of which approx. 10 g are introduced in the urethra during introduction (instillation).
Posology: Adult males: In general, the 12.5 g syringes are required for men in order to fill the urethra sufficiently. The content of a syringe is enough, more than one syringe should not be used. The effect sets in after 5 - 10 minutes and continues for approx. 20-30 minutes.
Women, children (aged 2 - 12 years) and adolescents (under 18 years of age): The effect of Cathejell is not documented that well, therefore a doctor should decide whether it is necessary to use it.
For these groups of patients, no specific dosage recommendations can be given, but in general, the quantity of gel to be introduced is to be adapted to the individual, anatomic conditions of the urethra.
In children, the absorption of Lignocaine through the mucous membranes in the organism may be increased, and so caution should be exercised. The maximum dose of 2.9 mg/kg BW Lignocaine hydrochloride should not be exceeded in children (aged 2 - 12 years).
Children under 2 years of age: Cathejell must not be used on children under the age of 2 years.
Dosage recommendations for high-risk patients: In elderly, weak or acutely sick patients as well as patients with impaired liver function or severe renal dysfunction, the dosage is to be adjusted accordingly. The maximum dosage must be calculated in mg Lignocaine hydrochloride/kg body weight (2.9 mg Lignocaine hydrochloride/kg BW).
Method of administration: For use in the urethra.
1. Clean or disnifect, if applicable, the external opening of the urethra.
2. Peel off the paper from the transparent cover-up to the tapered end of the blister.
3. Snap off the tip with a short sharp jabbing action into the blister pack.
4. Remove the tip completely so that it cannot be inserted accidentally into the urethra.
5. Squeeze out one drop of gel so that the application nozzle can be inserted more easily.
6. Insert the applicator nozzle into the meatus and instill slowly in one gradual and continuous motion. Do not release the syringe during administration.
7. Empty the accordion syringe completely and remove it pressed.
Wait 5 - 10 minutes before introducing the catheter/instrument.
Single-use product, dispose of gel residue from syringes that were not emptied completely.
Use for general anaesthesia and tracheal intubation: Posology: Adults and adolescents (aged > 12 years): Evenly distribute approx. 5 g across the bottom third of the tube (the hollow needle). In order to prevent drying out, the gel is only applied to the instrument immediately before administration. Do not get any gel into the lumen of the tube. The maximum dose is 16 g Cathejell for adults with a normal body weight.
Children (aged 2 - 12 years): In children, the absorption of Lignocaine through the mucous membranes in the organism may be increased, and so caution should be exercised. The maximum dose of 2.9 mg/kg BW Lignocaine hydrochloride should not be exceeded in children (aged 2 - 12 years).
Children under 2 years of age: Cathejell must not be used on children under the age of 2 years.
Dosage recommendations for high-risk patients: In elderly, weak or acutely sick patients as well as patients with impaired liver function or severe renal dysfunction, the dosage is to be adjusted accordingly. The maximum dosage must be calculated in mg Lignocaine hydrochloride/kg body weight (2.9 mg Lignocaine hydrochloride/kg BW).
Method of administration: For application to tubes, endoscopes and tracheal tubes.
Single-use product, dispose of gel residue from syringes that were not emptied completely.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in